RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ARCA Biopharma - Stock

ARCA Biopharma Employees 2024

ARCA Biopharma Employees

11

Ticker

ABIO

ISIN

US00211Y5069

WKN

A2PGY6

In 2024, ARCA Biopharma employed 11 people, a 0% change from the 11 number of employees in the previous year.

ARCA Biopharma Aktienanalyse

What does ARCA Biopharma do?

ARCA Biopharma Inc. is a biopharmaceutical company specializing in the development of therapies for cardiovascular diseases. The company was founded in 2004 and is headquartered in Westminster, Colorado, USA. ARCA Biopharma develops novel drugs tailored to the needs of patients with cardiovascular diseases. The history of ARCA Biopharma began when the company acquired exclusive rights to a technology for identifying genetic mutations associated with increased susceptibility to cardiovascular diseases. Thanks to this technology, ARCA Biopharma was able to develop more targeted, effective therapies based on the patient's genetic makeup. ARCA Biopharma's business model is based on the development of therapeutic technologies for cardiovascular diseases. The company utilizes its expertise in genomic research to develop customized, innovative drug therapies that are more targeted to the patient's genetic needs. ARCA Biopharma conducts intensive research and development work to develop significantly more effective drugs that are aimed at revolutionizing the market. ARCA Biopharma offers various types of medical therapies tailored to the needs of patients with cardiovascular diseases. The company focuses on RNA drug development and genomic research. RNA drugs are a relatively new type of medical therapy based on the regulation of gene expression. The company has several products in various stages of development tailored to the needs of patients with cardiovascular diseases. One of ARCA Biopharma's most successful products is Gencaro, a novel drug used in the treatment of heart failure. Gencaro is a beta-blocker specifically designed for patients with genetic markers associated with increased susceptibility to cardiovascular diseases. ARCA Biopharma has received multiple awards and numerous accolades for its innovation and research work. The company has partnerships with leading research and development organizations around the world to maximize its research efforts and accelerate the development of new innovative drugs. Overall, ARCA Biopharma aims to improve the lives of patients with cardiovascular diseases by providing tailored therapies that meet the genetic needs of the patient. The company has gained a reputation for its innovative research work and the development of highly effective drugs, and will undoubtedly play a leading role in the future development of therapies for cardiovascular diseases. ARCA Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining ARCA Biopharma's Employee Base

ARCA Biopharma's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ARCA Biopharma's operational capacity and future potential.

Year-to-Year Comparison

Assessing ARCA Biopharma's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

ARCA Biopharma's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in ARCA Biopharma’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about ARCA Biopharma Stock

How many employees does ARCA Biopharma have this year?

ARCA Biopharma has 11 undefined employees this year.

How many employees did ARCA Biopharma have compared to the previous year?

Compared to the previous year, ARCA Biopharma had 0% more employees.

What impact did the number of employees have on the company ARCA Biopharma?

The number of employees has a direct impact on the efficiency and productivity of ARCA Biopharma. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of ARCA Biopharma?

The number of employees can also have an impact on investors of ARCA Biopharma, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of ARCA Biopharma affect the company?

An increase in equity of ARCA Biopharma can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in ARCA Biopharma's equity affect the company?

A reduction in equity of ARCA Biopharma can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of ARCA Biopharma?

Some factors that can influence the equity of ARCA Biopharma include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of ARCA Biopharma so important for investors?

The equity of ARCA Biopharma is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at ARCA Biopharma influence the company?

The number of employees at ARCA Biopharma can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at ARCA Biopharma evolved in recent years?

In recent years, the number of employees at ARCA Biopharma has changed by 0.

How many employees does ARCA Biopharma currently have?

ARCA Biopharma currently has 11 undefined employees.

Why is the number of employees important for investors of ARCA Biopharma?

The number of employees is important for investors of ARCA Biopharma as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can ARCA Biopharma take to change the number of employees?

To change the number of employees, ARCA Biopharma can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does ARCA Biopharma pay?

Over the past 12 months, ARCA Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ARCA Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of ARCA Biopharma?

The current dividend yield of ARCA Biopharma is .

When does ARCA Biopharma pay dividends?

ARCA Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ARCA Biopharma?

ARCA Biopharma paid dividends every year for the past 0 years.

What is the dividend of ARCA Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ARCA Biopharma located?

ARCA Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von ARCA Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ARCA Biopharma from 6/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did ARCA Biopharma pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of ARCA Biopharma in the year 2023?

In the year 2023, ARCA Biopharma distributed 0 USD as dividends.

In which currency does ARCA Biopharma pay out the dividend?

The dividends of ARCA Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ARCA Biopharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von ARCA Biopharma

Our stock analysis for ARCA Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ARCA Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.